UKHSA unveils VDEC in ‘step change’ for UK’s growing vaccine capabilities
On Aug. 7, 2023, the UK Health Security Agency (UKHSA) unveiled its world-leading Vaccine Development and Evaluation Centre…
On Aug. 7, 2023, the UK Health Security Agency (UKHSA) unveiled its world-leading Vaccine Development and Evaluation Centre…
On Aug. 7, 2023, a National Institute of Health (NIH) supported study found that in 2021, an estimated…
On Aug. 1, 2023, more than 70 years after doctors at Johns Hopkins Hospital took Henrietta Lacks’ cervical…
On Jul. 31, 2023, Emergent BioSolutions announced that it was awarded a 10-year contract by the Biomedical Advanced…
On Jul. 28, 2023, COVID vaccine uptake among hospital workers at a Philadelphia teaching hospital rose from 86%…
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Health’s…
On Jul. 28, 2023, the U.S. U.S. Food and Drug Administration (FDA) approved RiVive, 3 milligram (mg) naloxone…
On Jul. 27, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $50.1 million to fund clinical-stage research…
Milestones in Diabetes illustrates major milestones from the first administration of the hormone insulin in 1921 to a…
On Jul. 24, 2023, the Journal JAMA reported there is evidence that Republican-leaning counties had higher COVID-19 death…
On Jul. 19, 2023, a team of scientists from the Translational Genomics Research Institute (TGen), part of the…
On Jul. 19, 2023, in a major breakthrough toward understanding and treating kidney disease, a nationwide research team…
On Jul. 18, 2023, the King County Department of Health issued a Health Advisory that Candida auris (C….
On Jul. 14, 2023, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
On Jul. 14, 2023, the UK Animal and Plant Health Agency reported that additional asymptomatic human detections of…
On Jul. 6, 2023, Eisai and Biogen announced that the U.S. Food and Drug Administration (FDA) had approved the…
On Jun. 29, 2023, the Centers for Disease Control and Prevention (CDC) endorsed the CDC Advisory Committee on…
On Jun. 29, 2023, the U.S. Food and Drug Administration approved Roctavian, an adeno-associated virus vector-based gene therapy…
On Jun. 27, 2023, researchers from Tel Aviv University announced they have developed an innovative gene therapy that…
On Jun. 26, 2023, the Centers for Disease Control and Prevention (CDC) announced they were collaborating with U.S….
On Jun. 22, 2023, the Institute for Health Metrics and Evaluation (IHME) reported that more than half a…
On Jun. 22, 2023, the U.S. Food and Drug Administration (FDA) approved Sarepta Therapeutics’s Elevidys, the first gene…
On Jun. 17, 2023, the Mississippi man known as “Case 1,” the first person to be diagnosed with…
On Jun. 6, 2023, the U.S. Food and Drug Administration (FDA) granted granted marketing authorization for the Cue COVID-19…
On Jun. 1, 2023, the National Institute of Allergy and Infectious Diseases and the National Cancer Institute reported…
On Jun. 1, 2023, Illumina announced the new PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts with unprecedented…
Milestones in Parkinson’s illustrates advancements in the disease from James Parkinson’s essay on ‘shaking palsy’ to development of…
On May 31, 2023, the California Institute for Regenerative Medicine (CIRM) awarded $10 million to five facilities as…
On May 31, 2023, the World Health Organization (WHO) announced it had assigned simple, easy to say and…
On May 26, 2023, the University of Gothenburg announced that for the first time worldwide, in yet another…